Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Neuroinflammation and Neurodegeneration Mechanisms, and S100 Proteins and Annexins.
A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative
Alzheimer's disease outlook: controversies and future directions
Temporal Dynamics and Biological Variability of Alzheimer Biomarkers
Exploring inflammation‐related protein expression and its relationship with TSPO PET in Alzheimer's disease
Equivalence of the FCSRT and RAVLT to detect medial Temporal lobe atrophy and tauopathy
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts
Neuroinflammation in Alzheimer disease
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settings
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Tau protein profiling in tauopathies: a human brain study
Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
Blood‐based multivariate methylation risk score for cognitive impairment and dementia
Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome
Dementia risk reduction in the African context: Multi‐national implementation of multimodal strategies to promote healthy brain aging in Africa (the Africa‐FINGERS project)
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study
Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset
Association of region‐specific hippocampal reduction of neurogranin with inflammasome proteins in <i>post mortem</i> brains of Alzheimer's disease
Blood biomarkers for Alzheimer’s disease in clinical practice and trials
Longitudinal changes in Alzheimer's‐related plasma biomarkers and brain amyloid
Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease
Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration
The potential clinical value of plasma biomarkers in Alzheimer's disease
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers
Role of biomarkers and emerging technologies in defining and assessing neurobiological recovery after sport-related concussion: a systematic review
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP
Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury